Transmission of Helicobacter pylori : a role for food? / Yvonne T. H. P. van Duynhoven and Rob de Jonge
Other TitlesTransmission de Helicobacter pylori : quel est le rôle des aliments? : résumé
Transmisión de Helicobacter pylori : intervienen los alimentos? : resumen
Duynhoven, Yvonne T. H. P. van & De Jonge, Rob. (2001). Transmission of Helicobacter pylori : a role for food? / Yvonne T. H. P. van Duynhoven and Rob de Jonge. Bulletin of the World Health Organization : the International Journal of Public Health 2001 ; 79(5) : 455-460 http://www.who.int/iris/handle/10665/74735
JournalBulletin of the World Health Organization : the International Journal of Public Health 2001 ; 79(5) : 455-460
DescriptionSummaries in English, French and Spanish
MetadataShow full item record
Showing items related by title and MeSH subject.
Alimohammadi, H.; Fouladi, N.; Salehzadeh, F.; Alipour, S.A.; Javadi, M.S. (2016-12)We examined the role of Helicobacter pylori infection as a cause of recurrent abdominal pain [RAP] among Iranian children in a population-based case-control study to determine the association between H. pylori infection and RAP among schoolchildren. A total of 1558 children aged 6-13 years were examined. Children with RAP confirmed by the Apley and Naish criteria were selected; 145 cases were selected for inclusion and were compared with 145 healthy children recruited from the same area. Both groups underwent stool antigen testing. The prevalence ...
Zahran, S.M.; Hamed, N.A.; Dafrawy, M.; Abdelaziz, H.K.; Morsi, M.G. (2013)To test the role of T helper cell Th1 immunity we recruited 24 patients with idiopathic thrombocytopenia associated with H. pylori seropositivity. They were divided into 2 groups: 12 with immune-mediated thrombocytopenia [Group 1] and 12 with non-immune mediated thrombocytopenia [Group 2]. We also recruited 10 individuals seronegative for H. pylori [Group 3] as controls. Initial platelet count was significantly lower in Group 1 than Group 2. H. pyloriwas eradicated in 10 of 12 patients in Group 1 and in all patients in Group 2. Transient improvement ...